George Papadopoulos

ORCID: 0000-0002-5442-1711
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Aortic aneurysm repair treatments
  • Cardiovascular Health and Disease Prevention
  • Trauma and Emergency Care Studies
  • Neutropenia and Cancer Infections
  • COVID-19 and healthcare impacts
  • Vascular Procedures and Complications
  • Emergency and Acute Care Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Aortic Disease and Treatment Approaches
  • Pathogenesis and Treatment of Hiccups
  • Healthcare Policy and Management
  • Atrial Fibrillation Management and Outcomes
  • Nail Diseases and Treatments
  • Nematode management and characterization studies
  • Infectious Aortic and Vascular Conditions
  • Cardiovascular Disease and Adiposity
  • Glaucoma and retinal disorders
  • Cardiac Arrhythmias and Treatments
  • Corneal surgery and disorders
  • Telemedicine and Telehealth Implementation
  • Antibiotic Use and Resistance
  • Diagnosis and Treatment of Venous Diseases

Takeda (United States)
2024

Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
2022

University Hospital of Heraklion
2016-2021

NIHR Birmingham Biomedical Research Centre
2021

University of Birmingham
2021

Yorkshire Cancer Research
2021

Urology Foundation
2021

Association for Cancer Surgery
2021

University of Crete
2005-2020

General University Hospital of Patras
2020

The mortality, length of hospitalization, and costs associated with invasive fungal infections (IFIs) in hospitalized patients were studied.This retrospective database study used data from the 2004 Healthcare Cost Utilization Project Nationwide In-patient Sample. Patients selected for inclusion based on diagnostic codes corresponding to an IFI. A control group was matched IFI high-risk conditions (i.e., cancer, infection human immunodeficiency virus, chronic obstructive pulmonary disease,...

10.2146/ajhp080325 article EN American Journal of Health-System Pharmacy 2009-09-18

Study Objective To determine the true institutional cost of treating invasive fungal infections in light recent advances diagnostic techniques and antifungal therapies for both treatment prophylaxis these infections. Design Economic analysis. Setting Academic medical center. Patients A total 200 patients discharged from hospital during 2004–2005 with a diagnosis proven, probable, or possible aspergillosis, cryptococcosis, candidiasis, zygomycosis (cases). were matched 1:1 fashion having...

10.1002/j.1875-9114.2012.01124 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2012-10-01

We sought to investigate the effect of autologous platelet-rich plasma (PRP) on healing rate diabetic foot ulcers in patients with diabetes and concomitant peripheral arterial disease (PAD). Diabetic ulceration presenting PAD who were treated local growth factors a single center, during 24-month period from May 2009 April 2011, retrospectively reviewed. Based severity PAD, subjects divided into groups A (Fontaine classification stages I, IIa, IIb) B III IV), those included latter being...

10.1177/1534734615575829 article EN The International Journal of Lower Extremity Wounds 2015-03-20

To evaluate the cost-effectiveness of posaconazole versus standard azoles in prevention invasive fungal infection (IFI) high-risk patients, using a pharmacoeconomic model that was adapted to Swiss setting.Decision tree models based on results two registration trials and subsequent Markov over patient lifetimes were developed for patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) neutropenia hematopoietic stem cell transplant recipients graft-versus-host disease...

10.1159/000313696 article EN Oncology 2010-01-01

To present our experience with the Ovation Abdominal Stent Graft System (TriVascular Inc., Santa Rosa, CA) during endovascular aneurysm repair (EVAR) and compare results according to type of anaesthesia.We conducted a single-centre retrospective study including patients who underwent EVAR using endograft between May 2011 July 2014. Outcome was evaluated regarding pre-, peri- immediate postoperative follow-up measures. Overall are reported, while additional analysis performed outcome groups...

10.1259/bjr.20140735 article EN British Journal of Radiology 2015-05-12

Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.A decision-analytic developed based on data randomized trial comparing with standard azole (fluconazole or itraconazole) therapy. The extrapolated lifetime horizon using one-month Markov cycles; survival specific underlying disease. Drug and treatment costs associated IFI...

10.1155/2012/583630 article FR cc-by Canadian Journal of Infectious Diseases and Medical Microbiology 2012-01-01

The results of a pharmacoeconomic study the cost-effectiveness posaconazole versus fluconazole in preventing invasive fungal infections (IFIs) patients with graft-versus-host disease (GVHD) are reported.The randomized clinical trial suggested that may be as effective for prevention IFIs recipients allogeneic cell transplants who develop severe GVHD and superior to reducing IFI-related deaths. Using published data from secondary sources, an economic model was developed estimate costs,...

10.2146/ajhp110149 article EN American Journal of Health-System Pharmacy 2012-01-04

<b>Purpose:</b> The aim of this study was to investigate the relationship between central corneal thickness and intraocular pressure measured by Goldmann applanation tonometry Pascal dynamic contour tonometry. <b>Patients Methods:</b> included 45 persons (90 eyes), divided into 4 groups: a) 10 normal volunteers (20 eyes); b) 16 patients (32 eyes) with primary open-angle glaucoma; c) 8 (16 normal-tension d) 11 (22 ocular hypertension. Intraocular tonometry, ultrasound pachymetry. evaluated....

10.1055/s-0035-1545792 article EN Klinische Monatsblätter für Augenheilkunde 2015-04-22

This study aims to measure and compare the ocular pulse amplitude using Pascal dynamic contour tonometry in normal persons glaucoma patients.20 patients (40 eyes) with primary open angle (Group A), 8 (16 tension B), 12 (24 hypertension C) were included study. Control group D) comprised 25 volunteers (50 eyes). Intraocular pressure was measured both Goldmann applanation slit-lamp tonometry. Ocular evaluated Statistical evaluation of differences intraocular among different groups performed...

10.1055/s-0034-1368220 article EN Klinische Monatsblätter für Augenheilkunde 2014-04-25

Refractory invasive aspergillosis (IA) is a life-threatening condition. Cost of treatment, although secondary, important if newer drugs are to be widely accepted. Posaconazole has been shown have activity against aspergillosis.Analyses were conducted compare the effectiveness and cost posaconazole 800 mg/day with those standard antifungal therapy, using Walsh et al. 2007 data. All-cause mortality total drug costs analyzed for three patient groups: All Refractory, Non-neutropenic, Neutropenic...

10.1185/03007995.2010.516110 article EN Current Medical Research and Opinion 2010-09-07

Abstract Of the spectroscopic methods available for characterization of dynamics heme protein active sites, time‐resolved resonance Raman spectroscopy (TR 3 ) is a powerful technique because excitation within π–π* electronic absorption transitions selectively enhances vibrational modes and bound‐proximal/distal ligands without interference from associated with matrix. On other hand, step‐scan (TRS 2 Fourier transform infrared (FTIR) has sensitivity resolution to detect, in addition bound...

10.1002/jrs.1313 article EN Journal of Raman Spectroscopy 2005-04-01

Oral topotecan has been recently brought into clinical practice at a dose of 2.3 mg/m2 for 5 days, every 3 weeks. Published data show quite high myelotoxicity. The aim this trial was to define the daily and treatment duration, which permits safe toxicity. study designed begin low dosage 1.5 escalated by increasing day-treatment duration. plan end up with days. In cases tolerability last given, we would then continue testing higher dosage. Treatment repetition planned be 21 Dosage levels were...

10.1097/cad.0b013e3283350092 article EN Anti-Cancer Drugs 2009-12-21

Purpose To associate the impact of aortic reconstruction using currently available grafts and endografts on pulse wave velocity in patients with abdominal aneurysm (AAA) to evaluate its effect early cardiac systolic function indices. Materials Methods Seventy-three consecutive AAA (mean age 70±8 years; all men) who underwent open (n=12) or endovascular repair (EVAR; n=61) were prospectively enrolled an observational cohort study. Left ventricular global longitudinal strain (GLS; important...

10.1177/1526602820976636 article EN Journal of Endovascular Therapy 2020-12-02

Cardiovascular diseases are among the leading causes of death in women. Significant gender differences have been reported patients with symptomatic carotid artery disease. The aim this study is to examine if female sex a predisposing factor for stenosis coronary bypass grafting (CABG) patients. We studied 965 CABG patients, 796 males and 169 females. combined risk factors predicting disease as history cerebrovascular accident (CVA), peripheral vascular (PVD), left main (LM) advanced age....

10.1510/icvts.2009.213249 article EN Interactive Cardiovascular and Thoracic Surgery 2009-08-17

Background:Many countries have various requirements for local economic analyses to assess the value of a new health technology and/or secure reimbursement. This study presents case an model developed cost-effectiveness posaconazole vs standard azole therapy (fluconazole/itraconazole) prevent invasive fungal infections (IFIs), which was adapted by at least 11 countries.Methods:Modeling techniques were used fluconazole/itraconazole as IFI prophylaxis in patients with acute myelogenous leukemia...

10.3111/13696998.2012.761633 article EN Journal of Medical Economics 2012-12-21
Coming Soon ...